BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30217414)

  • 21. IL-22 regulates iron availability in vivo through the induction of hepcidin.
    Smith CL; Arvedson TL; Cooke KS; Dickmann LJ; Forte C; Li H; Merriam KL; Perry VK; Tran L; Rottman JB; Maxwell JR
    J Immunol; 2013 Aug; 191(4):1845-55. PubMed ID: 23836059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Guanosine 5'-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway.
    Angmo S; Tripathi N; Abbat S; Sharma S; Singh SS; Halder A; Yadav K; Shukla G; Sandhir R; Rishi V; Bharatam PV; Yadav H; Singhal NK
    Sci Rep; 2017 Jan; 7():40097. PubMed ID: 28054602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogen Sulfide Attenuates Inflammatory Hepcidin by Reducing IL-6 Secretion and Promoting SIRT1-Mediated STAT3 Deacetylation.
    Xin H; Wang M; Tang W; Shen Z; Miao L; Wu W; Li C; Wang X; Xin X; Zhu YZ
    Antioxid Redox Signal; 2016 Jan; 24(2):70-83. PubMed ID: 26154696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo.
    Poli M; Asperti M; Ruzzenenti P; Mandelli L; Campostrini N; Martini G; Di Somma M; Maccarinelli F; Girelli D; Naggi A; Arosio P
    Biochem Pharmacol; 2014 Dec; 92(3):467-75. PubMed ID: 25241290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polychlorinated biphenyls (PCBs) inhibit hepcidin expression through an estrogen-like effect associated with disordered systemic iron homeostasis.
    Qian Y; Zhang S; Guo W; Ma J; Chen Y; Wang L; Zhao M; Liu S
    Chem Res Toxicol; 2015 Apr; 28(4):629-40. PubMed ID: 25686467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum hepcidin in inflammatory bowel diseases: biological and clinical significance.
    Bergamaschi G; Di Sabatino A; Albertini R; Costanzo F; Guerci M; Masotti M; Pasini A; Massari A; Campostrini N; Corbella M; Girelli D; Corazza GR
    Inflamm Bowel Dis; 2013 Sep; 19(10):2166-72. PubMed ID: 23867871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.
    Tandara L; Grubisic TZ; Ivan G; Jurisic Z; Tandara M; Gugo K; Mladinov S; Salamunic I
    Clin Biochem; 2015 Dec; 48(18):1252-7. PubMed ID: 26164540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMPK Serves as a Therapeutic Target Against Anemia of Inflammation.
    Wang M; Xin H; Tang W; Li Y; Zhang Z; Fan L; Miao L; Tan B; Wang X; Zhu YZ
    Antioxid Redox Signal; 2017 Aug; 27(5):251-268. PubMed ID: 27923278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between hepcidin level and renal anemia.
    Yang LN; Zhang P; Tang F; Wang G; Li FE
    Genet Mol Res; 2014 Sep; 13(3):7407-10. PubMed ID: 25222239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activity.
    Martin MW; Newcomb J; Nunes JJ; McGowan DC; Armistead DM; Boucher C; Buchanan JL; Buckner W; Chai L; Elbaum D; Epstein LF; Faust T; Flynn S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Lee JH; Metz D; Middleton S; Mohn D; Morgenstern K; Morrison MJ; Novak PM; Oliveira-dos-Santos A; Powers D; Rose P; Schneider S; Sell S; Tudor Y; Turci SM; Welcher AA; White RD; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Amouzegh P; Ermann M; Jenkins J; Johnston D; Napier S; Power E
    J Med Chem; 2006 Aug; 49(16):4981-91. PubMed ID: 16884310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment.
    Hong JH; Choi YK; Min BK; Park KS; Seong K; Lee IK; Kim JG
    Diabetes Res Clin Pract; 2015 Jul; 109(1):64-70. PubMed ID: 25998917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis.
    Shu T; Jing C; Lv Z; Xie Y; Xu J; Wu J
    Eur J Haematol; 2015 Jan; 94(1):67-73. PubMed ID: 24954786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
    Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
    Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of aminopyridines substituted with benzoxazole as orally active c-Met kinase inhibitors.
    Cho SY; Han SY; Ha JD; Ryu JW; Lee CO; Jung H; Kang NS; Kim HR; Koh JS; Lee J
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4223-7. PubMed ID: 20570511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
    Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
    Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of hepcidin in chronic mild stress-induced depression.
    Farajdokht F; Soleimani M; Mehrpouya S; Barati M; Nahavandi A
    Neurosci Lett; 2015 Feb; 588():120-4. PubMed ID: 25576700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepcidin as a central mediator of anemia of chronic diseases associated with obesity].
    Villarroel H P; Arredondo O M; Olivares G M
    Rev Med Chil; 2013 Jul; 141(7):887-94. PubMed ID: 24356737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-inflammatory cytokine interleukin-6-induced hepcidin, a key mediator of periodontitis-related anemia of inflammation.
    Han Y; Huang W; Meng H; Zhan Y; Hou J
    J Periodontal Res; 2021 Aug; 56(4):690-701. PubMed ID: 33656216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepcidin and its role in inflammatory bowel disease.
    Dudkowiak R; Neubauer K; Poniewierka E
    Adv Clin Exp Med; 2013; 22(4):585-91. PubMed ID: 23986220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of iron metabolism by hepcidin.
    Nemeth E; Ganz T
    Annu Rev Nutr; 2006; 26():323-42. PubMed ID: 16848710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.